Publication
Title
Marketing of unproven stem cell-based interventions: a call to action
Author
Abstract
Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.
Language
English
Source (journal)
Science translational medicine. - -
Publication
2017
ISSN
1946-6234
DOI
10.1126/SCITRANSLMED.AAG0426
Volume/pages
9 :397 (2017) , p. 1-5
ISI
000404734300002
Note
Article Number: eaag0426
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Law 
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 05.04.2018
Last edited 02.10.2024
To cite this reference